These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 26399646)

  • 1. Thromboelastography on plasma reveals delayed clot formation and accelerated clot lyses in HIV-1 infected persons compared with healthy controls.
    Rönsholt FF; Gerstoft J; Ullum H; Johansson PI; Katzenstein TL; Ostrowski SR
    BMC Infect Dis; 2015 Sep; 15():388. PubMed ID: 26399646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of coagulation and fibrinolysis in Irish Wolfhounds and age-matched control dogs using tissue plasminogen activator-augmented viscoelastic testing.
    Davis S; Fletcher DJ; Newman A; Brooks MB
    J Vet Emerg Crit Care (San Antonio); 2024; 34(3):222-230. PubMed ID: 38775137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does Tranexamic Acid Improve Clot Strength in Severely Injured Patients Who Have Elevated Fibrin Degradation Products and Low Fibrinolytic Activity, Measured by Thrombelastography?
    Moore HB; Moore EE; Chapman MP; Hansen KC; Cohen MJ; Pieracci FM; Chandler J; Sauaia A
    J Am Coll Surg; 2019 Jul; 229(1):92-101. PubMed ID: 30936005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombelastography and biomarker profiles in acute coagulopathy of trauma: a prospective study.
    Ostrowski SR; Sørensen AM; Larsen CF; Johansson PI
    Scand J Trauma Resusc Emerg Med; 2011 Oct; 19():64. PubMed ID: 22029598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discrepant fibrinolytic response in plasma and whole blood during experimental endotoxemia in healthy volunteers.
    Ostrowski SR; Berg RM; Windeløv NA; Meyer MA; Plovsing RR; Møller K; Johansson PI
    PLoS One; 2013; 8(3):e59368. PubMed ID: 23555024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global assays of fibrinolysis.
    Ilich A; Bokarev I; Key NS
    Int J Lab Hematol; 2017 Oct; 39(5):441-447. PubMed ID: 28497494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic hyperfibrinolysis after trauma: a pilot study of targeted proteomic analysis of superposed mechanisms in patient plasma.
    Banerjee A; Silliman CC; Moore EE; Dzieciatkowska M; Kelher M; Sauaia A; Jones K; Chapman MP; Gonzalez E; Moore HB; D'Alessandro A; Peltz E; Huebner BE; Einerson P; Chandler J; Ghasabayan A; Hansen K
    J Trauma Acute Care Surg; 2018 Jun; 84(6):929-938. PubMed ID: 29554044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulation status, fibrinolysis, and platelet dynamics in dogs with chronic inflammatory enteropathy.
    Wennogle SA; Olver CS; Shropshire SB
    J Vet Intern Med; 2021 Mar; 35(2):892-901. PubMed ID: 33665845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased plasma clot permeability and susceptibility to lysis are associated with heavy menstrual bleeding of unknown cause: a case-control study.
    Szczepaniak P; Zabczyk M; Undas A
    PLoS One; 2015; 10(4):e0125069. PubMed ID: 25909989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 14-Day thawed plasma retains clot enhancing properties and inhibits tPA-induced fibrinolysis.
    Huebner BR; Moore EE; Moore HB; Shepherd-Singh R; Sauaia A; Stettler GR; Nunns GR; Silliman CC
    J Surg Res; 2017 Nov; 219():145-150. PubMed ID: 29078874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered plasma fibrin clot properties in essential thrombocythemia.
    Małecki R; Gacka M; Kuliszkiewicz-Janus M; Jakobsche-Policht U; Kwiatkowski J; Adamiec R; Undas A
    Platelets; 2016; 27(2):110-6. PubMed ID: 25989112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of rotation thrombelastography in a model of systemic activation of fibrinolysis and coagulation in humans.
    Spiel AO; Mayr FB; Firbas C; Quehenberger P; Jilma B
    J Thromb Haemost; 2006 Feb; 4(2):411-6. PubMed ID: 16420574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Euglobulin clot lysis time reveals a high frequency of fibrinolytic activation in trauma.
    Ilich A; Kumar V; Ferrara MJ; Henderson MW; Noubouossie DF; Jenkins DH; Kozar RA; Park MS; Key NS
    Thromb Res; 2021 Aug; 204():22-28. PubMed ID: 34111811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective assessment of fibrinolysis in morbid obesity: tissue plasminogen activator resistance improves after bariatric surgery.
    Samuels J; Lawson PJ; Morton AP; Moore HB; Hansen KC; Sauaia A; Schoen JA
    Surg Obes Relat Dis; 2019 Jul; 15(7):1153-1159. PubMed ID: 31128997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coagulation in acutely ill patients with severe chronic liver disease: Insights from thromboelastography.
    Lloyd-Donald P; Vasudevan A; Angus P; Gow P; Mårtensson J; Glassford N; Eastwood GM; Hart GK; Bellomo R
    J Crit Care; 2017 Apr; 38():215-224. PubMed ID: 27978499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro assessment of the effect of dabigatran on thrombosis of adult and neonatal plasma: comparisons using thromboelastography and microscopic visualization of fibrin clot structure.
    Nossair FF; Chan HHW; Gantioqui J; Atkinson HM; Berry LR; Chan AKC
    Blood Coagul Fibrinolysis; 2017 Oct; 28(7):551-557. PubMed ID: 28505011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major obstetric haemorrhage: monitoring with thromboelastography, laboratory analyses or both?
    Karlsson O; Jeppsson A; Hellgren M
    Int J Obstet Anesth; 2014 Feb; 23(1):10-7. PubMed ID: 24342222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-Free DNA Modulates Clot Structure and Impairs Fibrinolysis in Sepsis.
    Gould TJ; Vu TT; Stafford AR; Dwivedi DJ; Kim PY; Fox-Robichaud AE; Weitz JI; Liaw PC
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2544-53. PubMed ID: 26494232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microfluidics contrasted to thrombelastography: perplexities in defining hypercoagulability.
    Lawson PJ; Moore HB; Moore EE; Gerich ME; Stettler GR; Banerjee A; Schulick RD; Nydam TL
    J Surg Res; 2018 Nov; 231():54-61. PubMed ID: 30278969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variable Resistance to Plasminogen Activator Initiated Fibrinolysis for Intermediate-Risk Pulmonary Embolism.
    Stubblefield WB; Alves NJ; Rondina MT; Kline JA
    PLoS One; 2016; 11(2):e0148747. PubMed ID: 26866684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.